2011 Fiscal Year Final Research Report
Chemoprevention for Barrett's esophageal adenocarcinogenesis by inhibiting bile acid receptor, FXR.
Project/Area Number |
21591695
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Kanazawa University |
Principal Investigator |
|
Project Period (FY) |
2009 – 2011
|
Keywords | 十二指腸食道逆流 / 食道腺癌 / Farnesoid X receptor(FXR) / ガグルステロン / Cyclooxygenase-2(COX-2) |
Research Abstract |
We examined chemopreventive effect of gugglesterone(GS), an antagonist of farnesoid X receptor, on Barrett's esophageal cancer using rodent duodenoesophageal reflux model. Animals were divided into 3 groups, high GS group, low GS group and control and sacrificed 20, 40, 50 weeks after operation. There were no significant differences between 3 groups in the incidences of hyperplasia, columnar epithelia, dysplasia, and carcinoma in all terms. These results suggested that GS had no preventive effect on the esophagocarcinogenesis in this model.
|
Research Products
(14 results)